Harvard Bioscience (HBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Sales | 105,171 | 111,171 | 108,864 | 108,179 | 85,772 |
| Cost of Goods | 57,475 | 58,831 | 58,672 | 56,372 | 44,089 |
| Gross Profit | 47,696 | 52,340 | 50,192 | 51,807 | 41,683 |
| Operating Expenses | 46,634 | 45,341 | 42,459 | 41,961 | 33,717 |
| Operating Income | 1,537 | 7,830 | 8,405 | 10,218 | 8,055 |
| Interest Expense | 955 | 584 | 752 | 677 | 277 |
| Other Income | -147 | -354 | -785 | 22 | 2,034 |
| Pre-tax Income | 435 | 6,892 | 6,868 | 9,563 | 9,812 |
| Income Tax | -288 | 2,398 | 1,579 | -9,452 | 2,673 |
| Net Income Continuous | 723 | 4,494 | 5,289 | 19,015 | 7,139 |
| Net Income Discontinuous | -2,553 | -2,124 | -1,477 | 0 | 94 |
| Net Income | $-1,830 | $2,370 | $3,812 | $19,015 | $7,233 |
| EPS Basic Total Ops | -0.06 | 0.09 | 0.14 | 0.66 | 0.24 |
| EPS Basic Continuous Ops | 0.02 | 0.16 | 0.19 | 0.66 | 0.24 |
| EPS Basic Discontinuous Ops | -0.08 | -0.07 | -0.05 | 0.00 | 0.00 |
| EPS Diluted Total Ops | -0.06 | 0.08 | 0.13 | 0.65 | 0.24 |
| EPS Diluted Continuous Ops | 0.02 | 0.15 | 0.18 | 0.65 | 0.24 |
| EPS Diluted Discontinuous Ops | -0.08 | -0.07 | -0.05 | 0.00 | 0.00 |
| EBITDA(a) | $5,572 | $12,088 | $12,823 | $14,224 | $11,507 |